- Home
- CRNX vs VCTR Comparison
CRNX vs VCTR Comparison
Compare CRNX & VCTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNX | VCTR |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.6B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CRNX | VCTR |
|---|---|---|
| Price | $45.24 | $62.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $71.00 | ★ $73.33 |
| AVG Volume (30 Days) | ★ 1.5M | 421.9K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 3.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.90 |
| Revenue | $1,535,000.00 | ★ $1,164,380,000.00 |
| Revenue This Year | $405.68 | $48.86 |
| Revenue Next Year | $1,034.87 | $16.77 |
| P/E Ratio | ★ N/A | $16.14 |
| Revenue Growth | ★ 47.74 | 34.31 |
| 52 Week Low | $24.10 | $47.00 |
| 52 Week High | $60.34 | $73.00 |
Technical Indicators
Market Signals| Indicator | CRNX | VCTR |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 46.91 |
| Support Level | $43.07 | $61.88 |
| Resistance Level | $45.16 | $63.87 |
| Average True Range (ATR) | 2.04 | 1.58 |
| MACD | 0.24 | 0.21 |
| Stochastic Oscillator | 79.37 | 46.46 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About VCTR Victory Capital Holdings Inc.
Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.